Jan Styczyński
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 55
- Acute Myeloid Leukemia Research 27
- Oncology top 1%
- Neutropenia and Cancer Infections 26
- Polyomavirus and related diseases 25
- Viral-associated cancers and disorders 22
- Infectious Diseases top 1%
- Epidemiology top 1%
- Cytomegalovirus and herpesvirus research 35
- Transplantation top 5%
-
- Acute Lymphoblastic Leukemia research 70
-
- Childhood Cancer Survivors' Quality of Life 44
- Co-authors
- Per LjungmanRafael de la CámaraMariusz WysockiDan EngelhardCatherine CordonnierSimone CesaroLidia GilKatherine N. Ward
- Partner nations
- PolandItalyNetherlands
In The Last Decade
Jan Styczyński
257 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 125
- Hematology 1.5k
- Oncology 2.0k
- Infectious Diseases 979
- Epidemiology 1.7k
- Transplantation 103
Countries citing papers authored by Jan Styczyński
This map shows the geographic impact of Jan Styczyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Styczyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Styczyński more than expected).
Fields of papers citing papers by Jan Styczyński
This network shows the impact of papers produced by Jan Styczyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Styczyński. The network helps show where Jan Styczyński may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Styczyński, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 11 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 0 | |
| 13 | 2022 | 11 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 63 | |
| 16 | 2020 | 5 | |
| 17 | 2020 | 102 | |
| 18 | 2019 | 0 | |
| 19 | Recommendations for the diagnosis and treatment of CMV infections. Polish Society of Epidemiology and Infectious Diseases | 2017 | 7 |
| 20 | Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia. | 2008 | 20 |
About Jan Styczyński
Jan Styczyński is a scholar working on Hematology, Oncology and Genetics, having authored 299 papers that have together received 4.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (70 papers), Hematopoietic Stem Cell Transplantation (55 papers), Childhood Cancer Survivors' Quality of Life (44 papers), Cytomegalovirus and herpesvirus research (35 papers), Acute Myeloid Leukemia Research (27 papers), Neutropenia and Cancer Infections (26 papers), Polyomavirus and related diseases (25 papers) and Viral-associated cancers and disorders (22 papers). The work is most often cited by research in Hematology (1.5k citations), Oncology (2.0k citations) and Infectious Diseases (979 citations). Jan Styczyński has collaborated with scholars based in Poland, Italy and Netherlands. Frequent co-authors include Per Ljungman, Rafael de la Cámara, Mariusz Wysocki, Dan Engelhard, Catherine Cordonnier, Simone Cesaro, Lidia Gil, Katherine N. Ward, Nicolaus Kröger and Mohamad Mohty. Their work appears in journals such as Bone Marrow Transplantation, Blood, Anticancer Research, Cancers and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.